On receipt, each referral must be transferred to the named high risk coordinators or director of breast screening without delay and be reviewed to make sure the inclusion criteria have been evidenced. This review must be completed by a consultant radiologist, consultant practitioner or breast clinician experienced in the full range of triple assessment. In the rare occurrence where women fulfill more than one risk criteria for very high risk screening (for example, BRCA1 gene mutation and previous radiotherapy to breast tissue when aged 15), the lead clinician should make an assessment regarding the most appropriate surveillance protocol. Make time for self-care: looking after your body and hair can really impact your confidence and help your mental health. Use a silk turban: silk turbans are great to prevent pulling when you’re sleeping as they prevent resistance that can lead to fall out.

From the 648 references identified, eleven were selected, ten of which had a longitudinal design. All studies were conducted in high-income countries, six evaluated the outcome in children, four in adolescents and one in young adults (<35 years). Of the studies that assessed the outcome in childhood, two found a positive association and the others showed a negative effect of being breastfed on bone mass. In adolescence, three studies showed a positive association between being breastfed and bone outcomes. Among adults, a negative effect of being breastfed exclusively for a longer period of time on bone mass was observed only in men. In women, there was no effect of being breastfed on bone mass. Conclusions All women on short-term recall should have previously attended assessment. Short-term recall should not be used as a routine outcome following assessment. Every effort should be made to obtain a definitive diagnosis at initial assessment. Short-term recall should only be made in exceptional circumstances and with fully informed consent as it is associated with significant anxiety. This guidance is aimed at BSP providers, commissioners, organisations and individuals who refer women into the very high-risk programme. These organisations include genetics services, oncology services and the breast screening after radiotherapy dataset ( BARD). Surveillance starts at 20 years for TP53, at 25 years for A-T homozygotes and at 30 years for PTEN, STK11 and CDH1. Evidence is required from the NHS clinical genetics service confirming the presence of a pathogenic variant and stating the name of the gene. Women previously treated with total body irradiation After the age of 50, a personal test result identifying a pathogenic variant is required to continue to access the very high risk programme, as the residual lifetime risk associated with a pathogenic variant will have reduced by this time. A woman with only a 50% chance of carrying this pathogenic variant would no longer reach the 40% lifetime risk threshold to access very high risk screening. More detailed information regarding these processes is available. How to decide lifetime risk in absence of genetic test

Last but certainly not least, I want to tell you about another great tool to protect yourself from fraud: Surfshark. Here is why you should get it now: Harvey NC, Robinson SM, Crozier SR, Marriott LD, Gale CR, Cole ZA, et al. Breast-feeding and adherence to infant feeding guidelines do not influence bone mass at age 4 years. Br J Nutr. 2009;102(6):915–20. the treating clinician (surgeon or oncologist) - for cancer patients found to carry a genetic mutation that meets the eligibility criteria for very high risk screening

when MRI surveillance would normally be offered but is not suitable (for example, because of claustrophobia) Short-term recalls ( STR) are defined as a further appointment to attend a screening assessment indicated before the normal screening interval (one year).A woman is considered to be at very high risk if she has a test result that identifies a germline pathogenic variant in a gene that would confer a 40% to 95% lifetime risk of breast cancer. When looking for goods online, a great deal can be very enticing. A Gucci bag or a new iPhone for half the price? Who wouldn’t want to grab such a deal? Scammers know this too and try to take advantage of the fact. Women in this group who were treated with radiotherapy between the ages of 10 and 35 years are referred into the NHS BSP very high risk programme.